A new case of prostate cancer is diagnosed every three minutes, and 90 men die from prostate cancer every day. Prostate biopsy is the "gold standard" for finding cancer of the prostate, however the procedure is associated with trauma, infection, bleeding and sampling bias. National statistics show that up to eight men must undergo a procedure that is unnecessary as documented by a negative biopsy. Moreover, it is well known that a biopsy of the prostate is associated with the possibility that cancer cells, if encountered, may be carried outside of the prostate capsule.
Given the inability to diagnose prostate cancer using the traditional system, medical professionals have started turning to imaging technology to determine the presence or absence of prostate cancer. Current data suggests that prostate cancer detection with MRI-Spectroscopy (MRI-S) has a sensitivity and specificity in the range of 89-92 percent. In fact, Peter Scardino, M.D., Chairman of the Departments of Urology and Surgery at Memorial Sloan-Kettering, has called MRI-S with the 3.0 Tesla magnet, "the next greatest diagnostic tool for prostate cancer detection."
National Prostate Cancer Coalition
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment